New focused radiation blasts returning prostate cancer in just 5 sessions
NCT ID NCT05746806
First seen Jan 03, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests a new, short course of highly focused radiation for men whose prostate cancer has returned after surgery to remove the prostate. The radiation is given in just 5 sessions, along with 6 months of hormone therapy. The goal is to see if this approach can control the cancer with fewer side effects than standard longer radiation courses. About 36 men will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Inselgruppe AG, Inselspital
Bern, 3010, Switzerland
-
Istituto Oncologico della Svizzera Italiana-Ente Ospedaliero Cantonale (IOSI-EOC)
Bellinzona, 6500, Switzerland
-
Kantonsspital Winterthur, Klinik für Radio-Onkologie
Winterthur, 8401, Switzerland
-
Universitätsspital Basel
Basel, 4031, Switzerland
-
Universitätsspital Zürich, Klinik für Radio-Onkologie
Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.